Effects of muroctasin on the activities of drug metabolizing enzymes in liver microsomes of rats. 1988

T Kamataki, and M Komori, and M Iwasaki, and H Ohi, and M Kitada, and T Miura, and K Ono
Division of Analytical Biochemistry, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.

1. Effects of repeated administration of N2-[(N-acetylmuramoyl)-L-alanyl-D-isoglutaminyl]-N6-stearoyl-L-lysine (MDP-Lys (L18), muroctasin) to female rats on the activities of drug metabolizing enzymes in liver microsomes were examined. The in vitro effects of the compound on the activities of drug metabolizing enzymes in liver microsomes from male rats were also investigated. 2. The subcutaneous administration of MDP-Lys (L18) at a dose of 1 mg/kg (high dose) caused slight but significant decrease in the contents of cytochrome P-450 and cytochrome b5. The daily subcutaneous injection at a dose of 0.1 mg/kg (middle dose) resulted in the induction of aminopyrine N-demethylase, aniline hydroxylase and 7-ethoxycoumarin O-deethylase. Such induction of the enzymes was seen only when calculated on the basis of microsomal protein but not wet weight of livers. The changes were relatively small as compared with those caused by phenobarbital. 3. At one week after the last injection of the high dose of MDP-Lys (L18), slightly higher levels of the contents of cytochrome P-450 and cytochrome b5 and the activity of NADPH-cytochrome c reductase were noted. The cessation of the administration tended to increase the activities of drug metabolizing enzymes in rats treated with the high dose of the drug. These changes were seen only when the activities were calculated on the basis of mg of microsomal protein. 4. MDP-Lys (L18) inhibited drug metabolizing enzymes in vitro to various extents depending on the substrate used.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D009245 NADH Dehydrogenase A flavoprotein and iron sulfur-containing oxidoreductase that catalyzes the oxidation of NADH to NAD. In eukaryotes the enzyme can be found as a component of mitochondrial electron transport complex I. Under experimental conditions the enzyme can use CYTOCHROME C GROUP as the reducing cofactor. The enzyme was formerly listed as EC 1.6.2.1. NADH Cytochrome c Reductase,Diaphorase (NADH Dehydrogenase),NADH (Acceptor) Oxidoreductase,NADH Cytochrome c Oxidoreductase,Dehydrogenase, NADH
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D010105 Oxygenases Oxidases that specifically introduce DIOXYGEN-derived oxygen atoms into a variety of organic molecules. Oxygenase
D010634 Phenobarbital A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations. Phenemal,Phenobarbitone,Phenylbarbital,Gardenal,Hysteps,Luminal,Phenobarbital Sodium,Phenobarbital, Monosodium Salt,Phenylethylbarbituric Acid,Acid, Phenylethylbarbituric,Monosodium Salt Phenobarbital,Sodium, Phenobarbital
D011335 Proadifen An inhibitor of drug metabolism and CYTOCHROME P-450 ENZYME SYSTEM activity. Propyladiphenin,Diethylaminoethyldiphenylpropyl Acetate,Proadifen Hydrochloride,SK&F-525-A,SK-525A,SKF-525-A,SKF-525A,Acetate, Diethylaminoethyldiphenylpropyl,Hydrochloride, Proadifen,SK 525A,SK&F 525 A,SK&F525A,SK525A,SKF 525 A,SKF525A
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D003573 Cytochrome b Group Cytochromes (electron-transporting proteins) with protoheme (HEME B) as the prosthetic group. Cytochromes Type b,Cytochromes, Heme b,Group, Cytochrome b,Heme b Cytochromes,Type b, Cytochromes,b Cytochromes, Heme,b Group, Cytochrome
D003577 Cytochrome P-450 Enzyme System A superfamily of hundreds of closely related HEMEPROTEINS found throughout the phylogenetic spectrum, from animals, plants, fungi, to bacteria. They include numerous complex monooxygenases (MIXED FUNCTION OXYGENASES). In animals, these P-450 enzymes serve two major functions: (1) biosynthesis of steroids, fatty acids, and bile acids; (2) metabolism of endogenous and a wide variety of exogenous substrates, such as toxins and drugs (BIOTRANSFORMATION). They are classified, according to their sequence similarities rather than functions, into CYP gene families (>40% homology) and subfamilies (>59% homology). For example, enzymes from the CYP1, CYP2, and CYP3 gene families are responsible for most drug metabolism. Cytochrome P-450,Cytochrome P-450 Enzyme,Cytochrome P-450-Dependent Monooxygenase,P-450 Enzyme,P450 Enzyme,CYP450 Family,CYP450 Superfamily,Cytochrome P-450 Enzymes,Cytochrome P-450 Families,Cytochrome P-450 Monooxygenase,Cytochrome P-450 Oxygenase,Cytochrome P-450 Superfamily,Cytochrome P450,Cytochrome P450 Superfamily,Cytochrome p450 Families,P-450 Enzymes,P450 Enzymes,Cytochrome P 450,Cytochrome P 450 Dependent Monooxygenase,Cytochrome P 450 Enzyme,Cytochrome P 450 Enzyme System,Cytochrome P 450 Enzymes,Cytochrome P 450 Families,Cytochrome P 450 Monooxygenase,Cytochrome P 450 Oxygenase,Cytochrome P 450 Superfamily,Enzyme, Cytochrome P-450,Enzyme, P-450,Enzyme, P450,Enzymes, Cytochrome P-450,Enzymes, P-450,Enzymes, P450,Monooxygenase, Cytochrome P-450,Monooxygenase, Cytochrome P-450-Dependent,P 450 Enzyme,P 450 Enzymes,P-450 Enzyme, Cytochrome,P-450 Enzymes, Cytochrome,Superfamily, CYP450,Superfamily, Cytochrome P-450,Superfamily, Cytochrome P450

Related Publications

T Kamataki, and M Komori, and M Iwasaki, and H Ohi, and M Kitada, and T Miura, and K Ono
December 1973, Biochemical pharmacology,
T Kamataki, and M Komori, and M Iwasaki, and H Ohi, and M Kitada, and T Miura, and K Ono
May 1974, Chemical & pharmaceutical bulletin,
T Kamataki, and M Komori, and M Iwasaki, and H Ohi, and M Kitada, and T Miura, and K Ono
September 1967, Science (New York, N.Y.),
T Kamataki, and M Komori, and M Iwasaki, and H Ohi, and M Kitada, and T Miura, and K Ono
January 1963, Experientia,
T Kamataki, and M Komori, and M Iwasaki, and H Ohi, and M Kitada, and T Miura, and K Ono
March 1968, Molecular pharmacology,
T Kamataki, and M Komori, and M Iwasaki, and H Ohi, and M Kitada, and T Miura, and K Ono
January 1992, The British veterinary journal,
T Kamataki, and M Komori, and M Iwasaki, and H Ohi, and M Kitada, and T Miura, and K Ono
March 1969, Japanese journal of pharmacology,
T Kamataki, and M Komori, and M Iwasaki, and H Ohi, and M Kitada, and T Miura, and K Ono
September 1975, Toxicology,
T Kamataki, and M Komori, and M Iwasaki, and H Ohi, and M Kitada, and T Miura, and K Ono
December 1964, The Journal of pharmacology and experimental therapeutics,
T Kamataki, and M Komori, and M Iwasaki, and H Ohi, and M Kitada, and T Miura, and K Ono
July 1968, Journal of biochemistry,
Copied contents to your clipboard!